《中国病案》2023年第24卷第4期·102·[5]WenjuanZhang,ZhaohuiZheng,etal.Evaluationof12differentassaysfordetectingANCAinChinesepatientswithGPAandMPA:amulticenterstudyinChina[J].ClinRheumatol,2019,38(12):3477-3483.[6]XiuzhuHou,JingLiu,TianchengWang,etal.Theperformanceofthechemiluminescentimmunoassayformeasuringserummyeloperoxidaseandproteinase3antibodies[J].Journalofclinicallaboratoryanalysis,2021,35(2):e23615.[7]McAdooSP,HallA,LevyJ,SalamaAD,etal.Proteinase-3antineutrophilcytoplasmantibodypositivityinpatientswithoutprimarysystemicvasculitis[J].JClinRheumatol,2012,18(7):336-340.[8]唐星磊,张文娟,王卫涛,等.临床患者血清抗中性粒细胞胞质抗体检测与疾病分布及相关性研究[J].风湿病与关节炎,2021,10(9):32-35.[9]郭荣荣,余晓洋,张文静,等.抗中性粒细胞胞浆抗体检测结果分析[J].世界最新医学信息文摘(连续型电子期刊),2020,20(89):228-229.[10]FainO,HamidouM,CacoubP,etal.Vasculitidesassociatedwithmalignancies:analysisofsixtypatients[J].ArthritisRheum,2007,57(8):1473-1480.[11]MahrA,BatteuxF,TubianaS,etal.Briefreport:prevalenceofantineutrophilcytoplasmicantibodiesininfectiveendocarditis[J].ArthritisRheumatol,2014,66(6):1672-1677.[12]MichaelPH,AnnaMP,FranziskaRG,etal.PR3-ANCAandpaneldiagnosticsinpediatricinflammatoryboweldiseasetodistinguishulcerativecolitisfromCrohn'sdisease[J].PloSone,2018,13(12):e0208974.[13]YanXu,FeiXu,WenjieLi,MengtingLi,etal.Thediagnosticroleandclinicalassociationofserumproteinase3anti-neutrophilcytoplasmicantibodiesinChinesepatientswithinflammatoryboweldisease[J].Scandinavianjournalofgastroenterology,2020,55(7):806-813.[14]YukiA,TomokiI,SakumaT,etal.Anti-proteinase3antineutrophilcytoplasmicantibodyreflectsdiseaseactivityandpredictstheresponsetosteroidtherapyinulcerativecolitis[J].BMCgastroenterology,2021,21(1):325-337.[15]SoI,HidetoshiT,KeiichiM,etal.RoleofSerumProteinase3AntineutrophilCytoplasmicAntibodiesintheDiagnosis,EvaluationofDiseaseSeverity,andClinicalCourseofUlcerativeColitis[J].Gutandliver,2022,16(1):92-100.(2022-05-05收稿)189例儿童不明原因发热临床特征回顾性分析...
